Experiment: 1MXL

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D-NOESY	10% WATER/90% D2O			6.7	1 atm	303
2	2D-TOCSY	10% WATER/90% D2O			6.7	1 atm	303
3	15N-NOESY	10% WATER/90% D2O			6.7	1 atm	303
4	15N13C-NOESY	10% WATER/90% D2O			6.7	1 atm	303
5	HCCHTOCSY	10% WATER/90% D2O			6.7	1 atm	303
6	15N-HSQC	10% WATER/90% D2O			6.7	1 atm	303
7	13C-HSQC	10% WATER/90% D2O			6.7	1 atm	303
8	HNHA	10% WATER/90% D2O			6.7	1 atm	303
9	CBCA(CO)NNH	10% WATER/90% D2O			6.7	1 atm	303
10	HNCACB	10% WATER/90% D2O			6.7	1 atm	303

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Varian	UNITYPLUS	600

NMR Refinement
Method	Details	Software
simulated annealing	REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE.	X-PLOR

NMR Ensemble Information
Conformer Selection Criteria	LEAST RESTRAINT VIOLATION
Conformers Calculated Total Number	100
Conformers Submitted Total Number	40
Representative Model	18 (n/a)

Additional NMR Experimental Information
Details	THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY ON 13C, 15N-LABELED TROPONIN C AND A SYNTHETIC TROPONIN I PEPTIDE

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	X-PLOR	3.1	BRUNGER
2	structure solution	XPLOR

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.